North American insurance investors focus on broker estimate resets, PGR/AIG divergence, and improving life insurance VII

Overview

This report is Morgan Stanley's summary of recent investor focus areas in North American insurance along with model updates for multiple companies. Core topics include whether insurance brokers have completed an estimate reset after Marsh's results, investor divergence following the downgrade of Progressive, AIG's relative attractiveness in a weak P&C environment, improving variable investment income at life insurers, and mortality and underwriting margin trends at Globe Life. The report also provides risk-reward frameworks, target prices, 2026e valuation multiples, and key earnings drivers for companies including Chubb, Brighthouse, and Corebridge.

Core views

The report remains constructive overall on the North American insurance industry but emphasizes structural differentiation more strongly. On brokers, after Marsh's results pressured sector performance, lower market expectations may support share prices, with Aon and Willis relatively better positioned due to business mix and second-half setup, while Ryan Specialty is more clearly affected by the slowdown in commercial property insurance. In P&C, Progressive's long-term underwriting capability is still recognized, but near term it faces slowing growth, intensifying competition, and claims inflation pressure; AIG, by contrast, is drawing more attention because of improving ROE and a valuation discount. In life insurance, improved variable investment income preannouncements and continued favorable mortality at Globe Life provide positive signals for sector earnings, though it remains necessary to distinguish between one-off investment income uplift and sustainable operating improvement.

Analysis framework

The report combines investor feedback, 3Q25 earnings and management guidance, model updates, peer valuation multiples, ROE/PB, P/E, underwriting margins, net investment income, variable investment income, capital return, and share price performance monitoring to assess short-term earnings changes and 12-month risk-reward across insurers. For individual stocks, it uses sum-of-the-parts valuation, 2026e EPS multiples, book value multiples, and scenario analysis.

Methodology notes

• Valuation frameworkSum-of-the-parts valuation

  sum-of-the-parts

  Companies such as Chubb, Brighthouse, and Corebridge are valued by applying peer multiples to different business lines and then summing them to derive the target price.

• Earnings driversBreakdown of insurance underwriting and investment income

  underwriting margin, combined ratio, net investment income, and variable investment income

  The report breaks down insurer earnings into underwriting performance, premium growth, claims/mortality, interest rates, and investment income to judge whether earnings improvement is sustainable.

• Risk-rewardBull/Base/Bear scenario analysis

  12-month target price range

  For key companies, the report lists bull, base, and bear scenarios, showing valuation multiples, EPS or BV assumptions, and key business drivers.

• Market positioningShare price performance and position monitoring

  weekly, quarter-to-date, year-to-date, and past 12-month performance

  The report assesses investor positioning and market sentiment through stock trading monitoring, institutional holdings, hedge fund long/short ratios, and net exposure.

Asset mapping & comparison

Structured mapping from thesis to named assets (strengths, weaknesses, peers, risks).

• Insurance Brokers

  industry sub-sector

  Strengths

  Consensus expectations have been revised down, and Aon and Willis may benefit from business mix, M&A, construction business, and improved second-half setup.

  Weaknesses

  Marsh's roughly 3% 3Q25 North America organic growth was weaker than expected, dragging on sector share prices; Ryan Specialty is affected by a slowdown in commercial property insurance and business flowing back to admitted markets.

  Comparison

  Aon and Willis are more likely than Marsh to defend expectations, while expectations for Ryan Specialty are more tempered.

  Risks

  Further declines in broker organic growth, a worse-than-expected slowdown in commercial property insurance, and earnings releases failing to validate the estimate reset.

• Progressive (PGR)

  P&C/auto insurance stock

  Strengths

  It is still viewed long term as one of the better auto underwriters among peers and may prove more resilient than peers during a difficult cycle.

  Weaknesses

  Near-term growth slowdown, intensifying competition, the Florida excess profit refund issue, and claims inflation may continue to pressure the combined ratio.

  Comparison

  Relative to AIG, PGR is stronger in long-term underwriting quality, but its near-term risk-reward is less clear than AIG's.

  Risks

  A sharper-than-expected growth slowdown, persistent claims inflation, and competition pressuring pricing and underwriting profit.

• AIG

  P&C stock

  Strengths

  The report believes AIG can achieve incremental ROE improvement while still trading at a discount to major peers.

  Weaknesses

  It still operates in a difficult P&C pricing environment, and overall sector weakness may limit the pace of valuation recovery.

  Comparison

  Against a backdrop of broad P&C weakness, investors view AIG as a relatively more attractive name.

  Risks

  ROE improvement falling short of expectations, continued decline in P&C pricing, and insufficient market confidence in discount narrowing.

• Globe Life (GL)

  life insurance stock

  Strengths

  3Q25 earnings were driven by favorable mortality, life underwriting margins improved, 2026 EPS guidance is $14.60–$15.30, and cash flow supports buybacks.

  Weaknesses

  Life insurance sales and agent growth remain weak, requiring the new work site enrollment initiative and CRM to improve efficiency.

  Comparison

  Compared with more macro-sensitive annuity companies, GL's near-term improvement is driven more by mortality and underwriting margins.

  Risks

  Mortality improvement proving unsustainable, agent growth missing targets, and deteriorating health insurance cost conditions.

• Chubb Ltd (CB.N)

  key covered P&C company

  Strengths

  Underwriting discipline, international business growth especially in Asia, capital return, and book value growth support the Equal-weight framework; target price is $295.

  Weaknesses

  North America commercial premium growth forecasts were cut due to intensifying competition.

  Comparison

  Valuation is about 10.9x 2026e P/E, broadly in line with the average multiple for commercial insurance peers.

  Risks

  Declining P&C pricing, deteriorating underwriting margins, global growth and FX headwinds, portfolio losses, catastrophes, or adverse reserve development.

• Brighthouse Financial Inc (BHF.O)

  life/annuity stock

  Strengths

  Valuation is low, and if equities rise and rates stay high, there is upside to variable annuity returns and capital return.

  Weaknesses

  Earnings are significantly affected by equities and rates, and macro volatility makes earnings less predictable than peers; rating is Underweight.

  Comparison

  The report believes peers offer better profitability and free cash flow conversion.

  Risks

  A sharp equity market decline, lower interest rates, capital return below expectations, pressure on variable annuity capital levels, or life claims ratios or annuity expenses above expectations.

• Corebridge Financial Inc (CRBG.N)

  life/retirement business stock

  Strengths

  Its spread, fee, and underwriting earnings are diversified, and fee-based business migration plus a flexible operating model support the Overweight rating and $39 target price.

  Weaknesses

  It remains affected by interest rates, equity markets, and changes in retirement business flows.

  Comparison

  Compared with peers that are more macro-sensitive or weaker in free cash flow conversion, Corebridge is viewed as having more defensive business adjustment capability.

  Risks

  A weaker rate environment, poor performance in macro-sensitive products, fund outflows, and uncertainty around transaction-related regulatory approvals or reinsurance arrangements.

• MetLife、Prudential、Voya

  life insurers sensitive to variable investment income

  Strengths

  Preannouncements show this quarter's variable investment income was better than the past few quarters, with MetLife near long-term expectations and Prudential and Voya above long-term expectations.

  Weaknesses

  The improvement may partly reflect one-off mark timing rather than fully sustainable trading activity or fundamental improvement.

  Comparison

  Prudential's model adjustment is more notable because variable investment income preannouncements were significantly better than previous expectations.

  Risks

  Variable investment income falling back, capital market volatility, and the improvement proving unsustainable.

Key data

• Report date2025-10-24Both the filename and the report title point to October 24, 2025.
• Sector viewNorth America P&C Attractive; North America Life/Annuity AttractiveThe table shows both North American P&C and life/annuity sector views as Attractive.
• Marsh 3Q25 North America organic growthabout 3%Growth was below expectations and was the trigger for share price pressure and estimate resets in the insurance broker sector.
• Progressive valuation debateabout 13x forward P/ESome investors believe the negative factors are already reflected in the share price, but the report still emphasizes near-term growth and underwriting challenges.
• AIG key view2026e ROE improvement while still trading at a discount to major peersInvestors are more positive on AIG's positioning when P&C pricing conditions are difficult.
• Globe Life 2026 EPS guidance$14.60–$15.303Q25 earnings were driven by favorable mortality, and management expects that trend to continue into 2026.
• Globe Life 2026 excess cash flow$600–700 millionOf this, about $80–85 million is for dividends and about $520–620 million is for buybacks.
• Chubb EPS update2025e/2026e EPS raised to $26.90/$29.01The increases were 0.3%/0.4%, with the target price maintained at $295/shr.
• Chubb target price and valuation$295/shr, about 10.9x 2026e P/E, about 1.3x 2026e BV excl AOCIThe base case still assumes strong underwriting performance continues.
• Chubb scenario target pricesBull $350; Base $295; Bear $243The bull case is based on ROE upside and multiple expansion, while the bear case considers underwriting losses and macro headwinds.
• Brighthouse target price and rating$46, UnderweightThe company has high macro sensitivity; despite its lower P/E, the report believes peers offer better profitability and free cash flow conversion.
• Corebridge target price and rating$39, OverweightThe investment case is based on diversified spread, fee, and underwriting earnings, as well as a flexible operating model.
• Life insurance model updatesMore notable adjustments for Prudential and Corebridge; modest adjustments for Brighthouse, Jackson, Lincoln, MetLife, and VoyaPrudential benefited from variable investment income preannouncements above expectations, while Corebridge reflects the impact of a financial supplement restatement.

Impact & implications

For portfolios, the report suggests the insurance sector should not be traded simply as a sector beta, but rather through selective positioning around earnings sustainability, valuation resets, and macro sensitivity. Within P&C, the ROE, underwriting, and capital return profiles of AIG and Chubb warrant more attention, while near-term pressure on Progressive has not yet fully cleared. Within life insurance, improving variable investment income and mortality help support sentiment recovery, but it remains necessary to verify whether the improvement comes from sustainable trading activity and fundamentals rather than one-off valuation timing factors.

Risks

• A down cycle in P&C pricing could compress premium growth and underwriting margins.
• Claims inflation, reserve inadequacy, or catastrophe losses could raise the combined ratio.
• Lower interest rates would weaken net investment income and pressure earnings for annuity and life insurers.
• Equity market volatility would affect variable annuities, account values, variable investment income, and capital levels.
• If broker organic growth continues to slow, estimate resets may prove insufficient.
• Some improvement in life insurance may come from one-off investment income timing rather than sustainable fundamentals.
• Global growth and FX headwinds may affect companies with greater international exposure such as Chubb.
• If capital return, buybacks, and free cash flow conversion come in below expectations, valuation support will weaken.

What to watch

• Whether upcoming results from Aon, Willis, and Ryan Specialty confirm that broker expectations have been sufficiently reset downward.
• Progressive's growth slowdown, the impact of the Florida excess profit refund, and changes in the combined ratio.
• Progress in AIG's 2026e ROE improvement and whether its valuation discount to peers can narrow.
• Whether improvement in variable investment income at MetLife, Prudential, and Voya is sustainable.
• Globe Life's mortality, life and health underwriting margins, and execution of its agent growth plan.
• Chubb's North America commercial premium growth, North America personal lines combined ratio, international business growth, and buyback pace.
• Brighthouse's capital buffer, variable annuity net outflows, and the impact of rates and equities on ROE.
• Corebridge's earnings path after the financial supplement restatement, migration of fee-based business, and progress on reinsurance transactions.